CINCINNATI–(BUSINESS WIRE)–Would maybe per chance 11, 2026–
HealthWarehouse.com, Inc. (OTCQB:HEWA) announced nowadays that its gain sales for the principle quarter ended March 31, 2026, totaled $6.3 million, a 58% lower from the quarter ended March 31, 2025, as the U.S. Meals and Drug Administration ended a nationwide shortage that allowed pharmacies to rating and supply compounded GLP-1 prescription medicines in some unspecified time in the future of a shortfall in provide of sign-name versions. The Firm reported a gain lack of $361,000 and Adjusted EBITDA of adversarial $28,000 for the quarter.
HealthWarehouse.com, a expertise company with a focal point on healthcare e-commerce, sells and delivers prescription and over-the-counter medicines to all 50 states as an Accredited Digital Pharmacy by the National Affiliation of Boards of Pharmacy (NABP). HealthWarehouse.com provides a platform eager in rising rating admission to to and reducing prices of healthcare products for shoppers and industry partners nationwide.
Joseph Peters, President and CEO, commented, “As anticipated, our income reflects the assemble of the FDA’s curtailment of compounded GLP-1 medicines in early 2025 as sign-name producers increased production to meet real are looking ahead to. At the identical time, we are rising our offerings by contemporary industry items and strategic partnerships that are already serving to contain the gap. Our scalable platform, combined with world-class buyer provider, positions us to capitalize on these development opportunities and proceed turning in price to each partners and customers.”
HealthWarehouse.com continues to make investments in proprietary expertise to stay on the forefront of contemporary developments and offerings on the earth of healthcare, specializing in buyer expertise, operational efficiency, and scalability. The Firm recently announced a brand contemporary strategic partnership with healthwords.ai, one among the area’s leading healthcare focused artificial intelligence firms.
“Our partnership with healthwords.ai represents a huge step for HealthWarehouse.com, combining monetary upside with the flexibility to leverage AI to streamline operations, pink meat up scalability, and flee development,” acknowledged Peters. “While AI will supplement how we work, the expertise, creativity, and commitment of our staff stay needed for us to dispute the area-class provider that sets us apart. We place a query to AI as a tool to empower our team, enabling them to focal point on increased-price work and innovation that pressure prolonged-term price for our customers and shareholders.”
2026 First Quarter Overview:
Acquire Gross sales:
Acquire sales for the three months ended March 31, 2026, reduced to $6.3 million from $15.0 million for the three months ended March 31, 2025, a lower of $8.7 million or 57.8%. Prescription sales had been $5.3 million for the principle quarter, down $9.1 million or 62.8% from $14.4 million for the identical duration final twelve months. The lower used to be totally on account of a decline in our sales for the partner products and companies (B2B) prescription industry, which were down $8.8 million or 71.9% from the principle quarter of 2025 on account of the expected good deal in our compounded GLP-1 product sales. First-quarter over-the-counter gain sales of $934,000 this twelve months increased by $357,000 or 61.9% from $577,000 in the identical duration final twelve months totally on account of increases in marketplace sales, offset by a superb deal in sales for the partner products and companies over-the-counter industry (B2B).
Depraved Profit:
Depraved profit for the principle quarter of 2026 used to be $3.3 million, a $1.2 million or 27.3% lower versus the identical duration in 2025, as B2B prescription sales declined and sales of over-the-counter products increased. First-quarter scandalous margin improved from 30.2% to 52.1% twelve months-over-twelve months as margins in the B2B prescription and B2C prescription agencies increased, offset by lower margins in the B2C over-the-counter agencies.
Working Prices:
Promoting, general and administrative prices totaled $3.6 million for the principle quarter of 2026, a lower of $664,000, or 15.5% in contrast with $4.3 million for first quarter of 2025. Expense decreases incorporated a $712,000 lower in delivery and delivery provides prices on account of reduced sales, and a $99,000 lower in salaries and associated prices. These decreases had been offset by a upward thrust of $111,000 in advertising and marketing and marketing prices.
Acquire Revenue (Loss) and Adjusted EBITDA: Acquire loss for the principle quarter of 2026 used to be $361,000, a $539,000 decline from gain income of $178,000 in the principle quarter final twelve months, totally on account of the lower in sales of compounded GLP-1 products. Adjusted EBITDA used to be adversarial $28,000 in the principle quarter of 2026, in contrast with sure $561,000 in the twelve months-earlier quarter.
| HEALTHWAREHOUSE.COM, INC. AND SUBSIDIARIES | |||||||
| CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) | |||||||
|
For the Three Months Ended |
|||||||
|
March 31, |
|||||||
|
2025 |
2025 |
||||||
| In hundreds | |||||||
| Acquire sales |
$ |
6,347 |
$ |
15,036 |
|||
| Price of sales |
3,042 |
10,492 |
|||||
| Depraved profit |
3,305 |
4,544 |
|||||
| Promoting, general and administrative prices |
3,617 |
4,281 |
|||||
| Revenue (loss) from operations |
(312 |
) |
263 |
||||
| Interest expense |
(49 |
) |
(23 |
) |
|||
| Revenue (loss) prior to taxes |
(361 |
) |
240 |
||||
| Revenue tax expense |
– |
(62 |
) |
||||
| Acquire income (loss) |
(361 |
) |
178 |
||||
| Most long-established stock: | |||||||
| Sequence B convertible contractual dividends |
(86 |
) |
(86 |
) |
|||
| Acquire income (loss) attributable to frequent stockholders |
$ |
(447 |
) |
$ |
92 |
||
| Per allotment recordsdata: | |||||||
| Acquire income (loss) – routine |
$ |
(0.01 |
) |
$ |
0.00 |
||
| Acquire income (loss) – diluted |
$ |
(0.01 |
) |
$ |
0.00 |
||
| Sequence B convertible contractual dividends |
$ |
(0.01 |
) |
$ |
0.00 |
||
| Acquire income (loss) attributable to frequent stockholders – routine |
$ |
(0.01 |
) |
$ |
0.00 |
||
| Acquire income (loss) attributable to frequent stockholders – diluted |
$ |
(0.01 |
) |
$ |
0.00 |
||
| Weighted reasonable frequent shares prominent – routine |
56,917 |
55,887 |
|||||
| Weighted reasonable frequent shares prominent – diluted |
56,917 |
68,249 |
Employ of Non-GAAP Financial Measures
HealthWarehouse.com, Inc. (the “Firm”) prepares its consolidated monetary statements based completely on the US on the entire favorite accounting solutions (“GAAP”). As effectively as to disclosing monetary results ready based completely on GAAP, the Firm discloses recordsdata relating to EBITDA and Adjusted EBITDA, that are frequently worn. As effectively as to adjusting gain income or gain loss to exclude interest, taxes, depreciation and amortization, alongside with amortization of comely of exercise lease asset, (“EBITDA”), Adjusted EBITDA moreover excludes stock-based completely compensation, and particular nonrecurring charges. EBITDA and Adjusted EBITDA are no longer measures of performance outlined based completely on GAAP. Nonetheless, Adjusted EBITDA is worn internally in planning and evaluating the Firm’s performance. Accordingly, administration believes that disclosure of this metric provides lenders and diversified shareholders an additional search of the Firm’s operations that, when coupled with GAAP results, provides a more total working out of the Firm’s monetary results.
Adjusted EBITDA have to no longer be regarded as an alternative to gain income, gain loss, or to gain cash offered by or worn in running actions, as a measure of running results or of liquidity. It may per chance maybe really maybe also honest no longer be the same to equally titled measures worn by diversified firms, and it excludes monetary recordsdata that some may per chance presumably per chance also honest take point to of crucial in evaluating the Firm’s performance.
Reconciliation of Acquire Loss (GAAP) to Adjusted EBITDA (Non-GAAP)
|
Three Months Ended |
||||||||
|
March 31, |
||||||||
|
2026 |
2025 |
|||||||
|
In hundreds |
||||||||
| Acquire income (loss) |
$ |
(361 |
) |
$ |
178 |
|||
| Interest expense |
49 |
23 |
||||||
| Revenue tax expense |
– |
62 |
||||||
| Amortization of ROU asset |
43 |
40 |
||||||
| Depreciation and amortization |
88 |
86 |
||||||
| EBITDA (non-GAAP) |
(181 |
) |
389 |
|||||
| Adjustments to EBITDA: | ||||||||
| Stock-based completely compensation |
153 |
172 |
||||||
| Adjusted EBITDA |
$ |
(28 |
) |
$ |
561 |
About HealthWarehouse.com
HealthWarehouse.com, Inc. (OTCQB: HEWA), a expertise company with a focal point on healthcare e-commerce, sells and delivers prescription and over-the-counter medicines to all 50 states as an Accredited Digital Pharmacy by the National Affiliation of Boards of Pharmacy (“NABP”). HealthWarehouse.com provides a platform eager in rising rating admission to and reducing prices of healthcare products for shoppers and industry partners nationwide. Primarily based mostly in Florence, Kentucky, the Firm operates The United States’s Leading On-line Pharmacy and is a pioneer in cheap healthcare. As one among the principle Accredited Digital Pharmacies by the National Affiliation of Boards of Pharmacy, HealthWarehouse.com products and companies the mission of providing cheap healthcare and fabulous patient products and companies to assist American citizens. Be taught more at
Forward-Taking a glance Statements
This announcement and the guidelines integrated by reference herein possess “forward-taking a glance statements” as outlined in federal securities licensed pointers, alongside with but no longer restricted to Portion 27A of the Securities Act of 1933, Portion 21E of the Securities Substitute Act of 1934, and the Private Securities Litigation Reform Act of 1995, which statements are in step with our unique expectations, estimates, forecasts and projections. Statements that are no longer historical facts, alongside with statements in regards to the beliefs, expectations and future plans and programs of the Firm, are forward-taking a glance statements. Exact results may per chance presumably per chance also honest differ materially from those expressed in forward taking a glance statements or in administration’s expectations. Critical elements which may per chance also house off or make a contribution to precise results being materially and adversely diversified from those described or implied by forward taking a glance statements encompass, among others, dangers associated to competition, administration of development, rating admission to to sufficient capital to fund our industry and our development, contemporary products, products and companies and applied sciences, doubtless fluctuations in running results, worldwide expansion, outcomes of factual complaints and claims, fulfillment heart optimization, seasonality, industrial agreements, acquisitions and strategic transactions, foreign alternate rates, machine interruption, cyber-attacks, rating admission to to sufficient stock, authorities legislation and taxation and fraud. Extra info about elements that presumably may per chance presumably per chance also affect HealthWarehouse.com’s monetary results is incorporated in HealthWarehouse.com’s audited Annual Reports and Quarterly Reports on hand at otcmarkets.com and prior filings with the Securities and Substitute Charge.
Behold source model on businesswire.com:
Dan Seliga, Chief Financial Officer, (800) 748-7001
KEYWORD: OHIO UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: ONLINE RETAIL TECHNOLOGY HEALTH GENERAL HEALTH ELECTRONIC COMMERCE PHARMACEUTICAL HEALTH TECHNOLOGY RETAIL ARTIFICIAL INTELLIGENCE INTERNET TELEMEDICINE/VIRTUAL MEDICINE
SOURCE: HealthWarehouse.com, Inc.
Copyright Substitute Wire 2026.
PUB: 05/11/2026 04:05 PM/DISC: 05/11/2026 04:05 PM
http://www.businesswire.com/news/dwelling/20260511766993/en
